TB-500 + BPC-157 + GHK-Cu
A triple healing combination adding GHK-Cu (copper peptide) to the BPC-157/TB-500 stack. GHK-Cu contributes collagen synthesis, tissue remodeling, and antioxidant properties that complement the regenerative and anti-inflammatory effects of the other two peptides. An advanced combination protocol used in regenerative medicine for comprehensive tissue healing and recovery.
Typical Dosage
Varies by supplier formulation. Typical: combined dose subcutaneous two or three times weekly for 4-8 weeks. Individual component doses are generally lower than standalone use due to synergistic effects.
Administration
Subcutaneous injection
Mechanism of Action
This triple combination adds the copper peptide GHK-Cu to the BPC-157/TB-500 healing stack, introducing a third distinct mechanism — copper-dependent enzymatic tissue remodeling — alongside the NO/growth factor signaling of BPC-157 and the actin-mediated cell migration of TB-500.
GHK-Cu contributes uniquely through its ability to deliver bioavailable copper to cells and activate copper-dependent enzymes. Lysyl oxidase, a copper-dependent enzyme, catalyzes the cross-linking of collagen and elastin fibers, which is essential for creating organized, structurally sound connective tissue rather than disorganized scar tissue. Superoxide dismutase (SOD), another copper-dependent enzyme, provides antioxidant defense at the wound site, protecting newly forming tissue from oxidative damage. GHK-Cu also stimulates the synthesis of collagen types I and III, elastin, glycosaminoglycans, and decorin — the fundamental building blocks of the extracellular matrix.
The theoretical three-layer synergy works as follows: TB-500 acts first by mobilizing repair cells through actin regulation and reducing acute inflammation. BPC-157 creates the vascular and biochemical infrastructure for repair through angiogenesis and growth factor upregulation. GHK-Cu then supports the remodeling phase — the final stage of wound healing where disorganized early repair tissue is replaced with properly structured, functional tissue. GHK-Cu's gene-regulatory effects (modulating expression of over 4,000 genes) may also amplify the effects of the other two peptides by creating a favorable transcriptional environment for regeneration. As with the dual BPC/TB stack, no clinical data exists for this specific triple combination.
Regulatory Status
Not FDA approved. Combination product from compounding pharmacies and peptide suppliers.
Risks & Safety
Common: injection site irritation, nausea, headache, transient fatigue. Serious: theoretical promotion of existing tumors (all three peptides promote cell proliferation and angiogenesis), complex unknown interactions between three bioactive compounds not studied together. Rare: allergic reactions, copper-related effects from GHK-Cu component. No clinical data on the triple combination. Not FDA approved.
Research Papers
2Published: December 31, 2025
Abstract
Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine. By acting on key pathways such as PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, peptides exert influence over tissue regeneration, inflammation resolution, and neuromuscular recovery. Wound-healing peptides such as BPC-157, TB-500, and GHK-Cu promote angiogenesis, integrin-mediated extracellular matrix remodeling, and fibroblast activation, whereas growth hormone secretagogues like ipamorelin, CJC-1295, tesamorelin, sermorelin, and AOD-9604 activate IGF-1 signaling and satellite cell repair. Recovery-enhancing agents such as epithalon, delta sleep-inducing peptide, and pinealon target circadian and mitochondrial regulators, and neuroactive peptides like selank, semax, and dihexa enhance brain-derived neurotrophic factor and HGF/c-Met pathways critical to neuroplasticity. Although preclinical studies are promising, there is a current lack of clinical trials. This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.
Published: December 31, 2025
Abstract
Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients. Given the increase in the development of peptides and increased marketing to patients for orthopaedic injuries, it is critical for orthopaedic surgeons to understand the current evidence behind these therapeutic peptides.
Related Peptides
Ara-290
A non-erythropoietic peptide derived from erythropoietin (EPO) that activates the innate repair receptor (IRR) for tissue protection and nerve regeneration. Engineered to retain EPO's powerful tissue-protective signaling while completely eliminating its red blood cell-stimulating effects. Particularly promising for neurological injuries and ischemic tissue damage.
BPC-157
Body Protection Compound-157 — a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. The most widely studied regenerative peptide, with extensive animal research demonstrating healing effects on tendons, ligaments, muscles, the gut, and multiple organ systems. Uniquely stable in gastric acid, enabling both injectable and oral administration.
BPC-157 + TB-500
A combination product pairing BPC-157 and TB-500 in a single vial, targeting complementary healing pathways. BPC-157 provides localized gut, tendon, and ligament repair through VEGF and NO modulation, while TB-500 drives systemic tissue regeneration through actin-mediated cell migration. The most popular peptide combination in regenerative medicine protocols.
Dermorphin
An opioid heptapeptide originally isolated from the skin secretions of the South American tree frog Phyllomedusa sauvagei. Approximately 30-40 times more potent than morphine at the mu-opioid receptor. Highly controversial due to widespread abuse in horse racing for its pain-masking and performance-enhancing effects, which has led to numerous doping scandals and animal welfare concerns.